By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



22 Raul Wallenberg Street

Tel Aviv    69719  Israel
Phone: 972-3-6449556 Fax: 972-3-6449558


Medical Device

Company News
SteadyMed (STDY) Provides Insights On Recent Corporate Developments And Reports Second Quarter 2015 Financial Results 8/14/2015 9:57:20 AM
SteadyMed (STDY) To Provide Insights On Recent Corporate Developments And Report Second Quarter 2015 Financial Results 8/6/2015 10:39:30 AM
SteadyMed (STDY) Completes Program Of Human Factors Studies Validating Usability Of Trevyent 7/7/2015 7:19:10 AM
SteadyMed (STDY) And Cardiome Pharma Corp. (COM.TO) Enter Into A License Agreement For The Commercialization Rights To Trevyent Outside The U.S. 6/29/2015 7:42:10 AM
SteadyMed (STDY) Adds Significant Commercial Expertise To Its Board Of Directors With The Appointment Of Elizabeth A. Cermak 6/18/2015 7:23:37 AM
SteadyMed (STDY) To Present At The JMP Securities Life Sciences Conference 6/16/2015 10:51:52 AM
SteadyMed (STDY) Reports Recent Developments, Financial Highlights And First Quarter 2015 Financial Results 5/14/2015 7:49:04 AM
SteadyMed (STDY) Submits Application For Orphan Drug Designation For Trevyent For Pulmonary Arterial Hypertension 5/7/2015 7:37:59 AM
SteadyMed (STDY) Granted Additional U.S. Patent With Patent Term Extension 4/22/2015 8:19:56 AM
SteadyMed (STDY) Appoints David W. Nassif As Its Full Time Executive Vice President And Chief Financial Officer 4/8/2015 8:27:22 AM